Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Wiesner

Showing results (101-110 of 306) with videos related to

Pageof 31
Sort By:
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 1998
An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoralT M Pasha, R H Wiesner, L M Dahlke, et al.
Digestive Diseases and Sciences|July 1, 1987
Lymphocyte subsets in primary sclerosing cholangitisK D Lindor, R H Wiesner, J A Katzmann, et al.
Mayo Clinic Proceedings|May 1, 1989
Endotheliitis in hepatic allograftsJ Ludwig, K P Batts, M Ploch, et al.
Journal of Hepatology|March 9, 2000
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic diseaseN N Zein, A S Abdulkarim, R H Wiesner, et al.
Annals of Internal Medicine|November 1, 1988
Primary sclerosing cholangitis and celiac disease. A novel associationJ E Hay, R H Wiesner, R G Shorter, et al.
Alimentary Pharmacology & Therapeutics|July 12, 2012
Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipientsA B Mohabbat, W J Sandborn, E V Loftus, et al.
AJR. American Journal of Roentgenology|November 1, 1991
Primary sclerosing cholangitis: value of cholangiography in determining the prognosisD A Craig, R L MacCarty, R H Wiesner, et al.
Transplantation|August 29, 1998
Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantationC Madalosso, N F de Souza, D M Ilstrup, et al.
Transplantation|February 27, 1997
Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allograftsH I Aguilar, J L Steers, R H Wiesner, et al.
Chest|May 1, 1990
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiographyM J Krowka, A J Tajik, E R Dickson, et al.
Pageof 31

Showing results (101-110 of 306) with videos related to

Sort By:
Pageof 31
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 1998
An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoralT M Pasha, R H Wiesner, L M Dahlke, et al.
Digestive Diseases and Sciences|July 1, 1987
Lymphocyte subsets in primary sclerosing cholangitisK D Lindor, R H Wiesner, J A Katzmann, et al.
Mayo Clinic Proceedings|May 1, 1989
Endotheliitis in hepatic allograftsJ Ludwig, K P Batts, M Ploch, et al.
Journal of Hepatology|March 9, 2000
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic diseaseN N Zein, A S Abdulkarim, R H Wiesner, et al.
Annals of Internal Medicine|November 1, 1988
Primary sclerosing cholangitis and celiac disease. A novel associationJ E Hay, R H Wiesner, R G Shorter, et al.
Alimentary Pharmacology & Therapeutics|July 12, 2012
Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipientsA B Mohabbat, W J Sandborn, E V Loftus, et al.
AJR. American Journal of Roentgenology|November 1, 1991
Primary sclerosing cholangitis: value of cholangiography in determining the prognosisD A Craig, R L MacCarty, R H Wiesner, et al.
Transplantation|August 29, 1998
Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantationC Madalosso, N F de Souza, D M Ilstrup, et al.
Transplantation|February 27, 1997
Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allograftsH I Aguilar, J L Steers, R H Wiesner, et al.
Chest|May 1, 1990
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiographyM J Krowka, A J Tajik, E R Dickson, et al.
Pageof 31